Clinical Trials on Bladder Cancer in United Kingdom
Total 24587 results
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | Detrusor OveractivityUnited Kingdom
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
ImmunityBio, Inc.Active, not recruiting
-
University of ChicagoNot yet recruitingBladder CancerUnited States
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknown
-
Jonsson Comprehensive Cancer CenterWithdrawnInfiltrating Bladder Urothelial CarcinomaUnited States
-
University Hospitals Bristol and Weston NHS Foundation...SanofiUnknown
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Matthew GalskyGenentech, Inc.CompletedUrothelial/Bladder Cancer, NosUnited States
-
Johns Hopkins UniversityRecruiting
-
Brigham and Women's HospitalMerck Sharp & Dohme LLCRecruitingBladder CancerUnited States
-
Baylor College of MedicineActive, not recruitingBladder CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
University of Kansas Medical CenterRecruitingBladder CancerUnited States
-
University of Kansas Medical CenterAmerican Cancer Society, Inc.Active, not recruitingBladder CancerUnited States
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
University of Colorado, DenverAmerican Urological AssociationRecruiting
-
University of MiamiActive, not recruitingBladder CancerUnited States
-
University of MichiganCompletedBladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
University of Kansas Medical CenterNational Center for Advancing Translational Sciences (NCATS)Active, not recruitingBladder CancerUnited States
-
Ethicon Endo-SurgeryNovella Clinical; Data & Inference, Inc.CompletedOveractive BladderUnited States, Sweden, United Kingdom
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
National Cancer Institute (NCI)RecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Matthew GalskyMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
Fox Chase Cancer CenterCompletedMuscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary TractsUnited States
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
University of Kansas Medical CenterCompletedBladder CancerUnited States
-
University of Kansas Medical CenterCompletedBladder Cancer | Low Testosterone LevelsUnited States
-
PPsanalyticsAnchorDx Medical Co., Ltd.; Specialty NetworksTerminatedBladder CancerUnited States
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder CancerUnited States
-
M.D. Anderson Cancer CenterGE HealthcareActive, not recruitingBladder CancerUnited States
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Icahn School of Medicine at Mount SinaiNational Institute of Nursing Research (NINR); University of WashingtonRecruitingBladder CancerUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); VA Long Beach Healthcare System; Nonagen Bioscience...Recruiting
-
Mundipharma Research LimitedTerminatedSevere Caner PainUnited Kingdom
-
Johns Hopkins UniversityRecruiting
-
University of UtahBristol-Myers SquibbActive, not recruitingBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting